Evaluation of a Commercial Program on Weight Loss and Health Outcomes

The purpose of this study is to examine the acceptability and efficacy of a modified Weight Watchers program over 24 weeks. Assessments will be conducted at 0, 3, and 6 months.

Study Overview

Status

Completed

Detailed Description

The following assessment measures will be taken at 0, 3, and 6 months:

Weight measurements. Weight will be taken according to the National Health and Nutrition Examination survey anthropometry procedures manual. Weight will be measured in kilograms to the nearest 0.1 kg using a calibrated digital scale (Tanita, Inc.) with participants in light clothing and no shoes. Two measurements will be taken. and if the measures differ by more than 0.2 kg, a third measure will be taken. An average of the closest two measures will be calculated and used for data entry.

Waist circumference. Waist circumference will be assessed at baseline, 3 and 6 months. Waist circumference will be taken according to the National Health and Nutrition Examination survey anthropometry procedures manual. Measurements will be taken to the nearest 0.1cm, at the top of the pelvis ilium (just above the hip bone) with a non-stretchable tape measure, without compressing the skin, at the end of normal expiration. Two measurements will be taken with a third if the first two do not fall within 0.5 cm.

Aerobic stamina. Aerobic stamina will be assessed using the 6 minute walk test. Distance traveled in meters (m) is the outcome.

Flexibility. Flexibility will be assessed with the Classic Sit and Reach Test and reported in inches less than or greater than reached on a 20 inch reference mark as measured on a yard stick placed between the legs.

Food Cravings. The Food Craving Inventory-II (FCI-II) is a validated self-report measure for general cravings and cravings for specific types of foods and will be completed at baseline, Months 3 and 6. Respondents rate the frequency of cravings since the last time they completed the survey for each of 33 food items using a five-point Likert scale (1, never; 2, rarely; 3, sometimes; 4, often; 5, always/almost every day). The FCI-II consists of 5 scales (sweets, high fats, carbohydrates/starches, fast food fats, and fruits & vegetables) that constitute the higher order construct of food cravings (the total score).

Happiness. The Oxford Happiness Questionnaire will be used to assess happiness at 0, 3, and 6 months. The OHQ is a validated self-report measure for broad personal happiness. Respondents rate 29 sentences on a 6 point Likert scale (1, strongly disagree; 6, strong agree).

Sleep. Participants will be asked to complete the Pittsburgh Sleep Quality Index (PSQI) to assess sleep quality and duration at 0, 3, 6. The PSQI is a validated self-report measure of sleep duration and sleep quality. The PSQI examines seven components of sleep quality retrospectively over a period of four weeks: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction over the last month. The patient self-rates each of these seven areas of sleep. Scoring of answers is based on a 0-3 scale, whereby '3' reflects the negative extreme on the Likert scale. The global score is generated by summing up all seven component scores and ranges from 0 to 21, with higher values corresponding to reduced sleep quality.

Weight related quality of life. The Impact of Weight on Quality of Life-Lite (IWQOL-Lite) is a validated self-report measure for an individual's perception of how their weight affects their day-to-day life. Respondents rate the degree to which their weight affects them on 31 items using a five-point Likert scale (1, never true; 2, rarely true; 3, sometimes true; 4, usually true; 5, always true). The IWQOL-Lite consists of 5 scales (physical function, self-esteem, sexual life, public distress, and work).

Perceived Hunger. The Visual Analogue Scale (VAS) measures sensations that range across a continuum of values and cannot be easily directly measured. Operationally, the VAS is a horizontal line measuring exactly 100 mm in length, anchored by word descriptors (i.e., Not at all hungry, Extremely hungry) at each end. Participants will be asked to complete a three item VAS by placing a mark on the line at the point they feel represents their response to the question.

Program Satisfaction. The Satisfaction Survey is a self-administered survey with 25 items scored on a 5-point Likert scale. This measure will be completed at only at 6 months.

Study Type

Interventional

Enrollment (Actual)

152

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Chapel Hill, North Carolina, United States, 27514
        • University of North Carolina at Chapel Hill

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Body mass index (BMI) between 25 and 43 kg/m²
  • Ability to read and speak English
  • All ethnic groups will be recruited
  • Self-report desire to lose weight and willing to follow study recommendations
  • Use of an iPhone with iOS 8.0 or later for use on a daily basis, and basic app skills
  • Have access to the internet via a computer, and basic computer skills

Exclusion Criteria:

  • Currently following a commercial weight-loss program (including Weight Watchers) or who followed a weight loss program in the previous 6 months or who were members of Weight Watchers within the past 12 months
  • Another member of the household participating in the study.
  • Pregnant or nursing, or planning on becoming pregnant over the next 9 months.
  • Planning to relocate in the next 9 months
  • Involvement in another research study that would interfere with participation in this study
  • Excessive alcohol intake or dependence
  • Recent weight loss of ≥ 5 kg in the previous 6 months.
  • Report health problems that make weight loss or unsupervised exercise unsafe or unreasonable (e.g., orthopedic limitations, heart problems, history or heart attack or stroke)
  • History of clinically diagnosed eating disorder.
  • Untreated thyroid disease or and changes in dose or type of thyroid medication over previous 6 months
  • Chronic/inflammatory gastrointestinal disorders (Irritable Bowel Syndrome acceptable)
  • Taking any prescription medication with known effects on appetite or weight
  • Previous surgical procedure for weight loss.
  • Major surgery within the previous 6 months.
  • Resting systolic blood pressure >160 mmHg or resting diastolic blood pressure >100 mmHg
  • Diuretic use over 1.5mg per day
  • Diagnosis of type 1 or type 2 diabetes
  • Presence of implanted cardiac defibrillator or pacemaker.
  • History of presence of cancer within past 5 years or current treatment for cancer (completely resected basal or squamous cell carcinoma acceptable if treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Modified Weight Watchers plan
Modified Weight Watchers Plan which includes a food plan, activity plan, group support and cognitive behavior modification. Weekly study-specific group meetings; electronic tools through iPhone app for 24 weeks.
Weight Watchers is a structured lifestyle modification program that includes a food plan based on balanced diet and healthy eating, activity plan designed to promote progressive physical activity increase, group support and cognitive behavior modification. Participants attend weekly in-person group meetings led by a trained Weight Watchers meeting leader and have a suite of electronic tools available through an iPhone app.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight Change
Time Frame: 0 - 6 months
Mean Change in body weight (kg) Body weight will be assessed on a calibrated digital scale and recorded to the nearest 0.1 kg.
0 - 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Achieving a weight loss of 5% or more
Time Frame: 0 - 6 months
% participants achieving a weight loss of 5% initial body weight or more
0 - 6 months
Achieving a weight loss of 5% or more
Time Frame: 0 - 3 months
% participants achieving a weight loss of 5% initial body weight or more
0 - 3 months
Weight Change
Time Frame: 0 - 3 months
Mean Change in body weight (kg)
0 - 3 months
Waist circumference change (cm) (mean)
Time Frame: 0 - 3 months
Waist circumference will be measured at the iliac crest
0 - 3 months
Waist circumference change (cm) (mean)
Time Frame: 0 - 6 months
Waist circumference will be measured at the iliac crest
0 - 6 months
Relationship between fitness, flexibility and psychosocial measures with weight change
Time Frame: 0 - 6 months
The relationship between weight change and any of these measures will be assessed.
0 - 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 27, 2017

Primary Completion (ACTUAL)

August 31, 2017

Study Completion (ACTUAL)

August 31, 2017

Study Registration Dates

First Submitted

January 27, 2017

First Submitted That Met QC Criteria

January 27, 2017

First Posted (ESTIMATE)

January 31, 2017

Study Record Updates

Last Update Posted (ACTUAL)

May 18, 2018

Last Update Submitted That Met QC Criteria

May 17, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 16-3421

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Modified Weight Watchers plan

3
Subscribe